I think the only way to get a clear answer is a FOIA

FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

Diving into Trust: ANSI's 2027 Paper Challenge Out from the buzz of New York, the American National Standards Institute (ANSI) has stirred up some real brain-teasing talk for students across the country. Kicking off the 2027 Student Paper Competition, they're handing students a chance to ponder a question we take for granted every day. Do we ever truly consider what makes...

Third Quarter Reflections: Big Changes, Mixed Results Alright, Richmond Mutual Bancorporation just dropped their third quarter results for 2026 and let's just say, it's got more layers than an onion. Richmond's the parent of First Bank Midwest, and their latest numbers tell a tale of a merger aftermath with Farmers Bancorp. They've pulled off a balance sheet expansion,...

Cleaning Up Confusion on Dental Visits Never thought I'd be waxing poetic about gum health, but here we are. You know what they say, ain't no business like show business—and today's show is all about the pearly whites context, courtesy of Dr. Calvin Despain over in Moses Lake, Washington. Apparently, keeping that grin free from plaque isn't as simple as a quick brush...

Data Breach Drama Hits Tradier Brokerage Picture a broker-dealer like Tradier Brokerage, out in Charlotte, getting its customers' details hanging out there for the world to see. A calamity, courtesy of a cyberattack on their third-party vendor, Etna Software Corp. And we're talking Social Security numbers, tax IDs—emails across Texas and Massachusetts were popping up...

Amid the ever-turbulent waves of industrial demand and environmental expectations, Novelis Inc. is set to lay bare its fiscal cards for Q2 of 2027. Circle November 5 on your calendar—this is when Steve Fisher and Dev Ahuja aim to sift through the heaps, scrutinize numbers, and spell out their game plan for investors via a conference call. Get your coffee ready for this...

Rising Above the Grass Well, here's a twist: ANTHBOT's latest robot mower, the N8, caught the eyes of TIME magazine and snagged a spot on their Best Inventions of 2026 list. A lawnmower? You bet. And not just any lawnmower—this one's doing a whole song and dance with its 4-in-1 approach that'll make any garden-owning homeowner's life simpler. Kudos to them for shaking...

When the mercury dips, how far can your electric scooter really take you? Apollo Scooters has put some meat on the bones of this question, digging through over half a million rides to bust the myth that chillier days chop your scooter's range by half. Reality Check on Winter Range Loss For years, folks have griped that cold weather slashes electric vehicle range by a...

A New Chapter for a Seasoned Entrepreneur There's a certain irony in a seasoned business vet stepping into a new role at his own daughter's company, and that's exactly what's unfolding with the Bailors. Huntsville's own BAILOR isn't just another growth strategy company; it's the embodiment of a father-daughter dream team. After years as the ordinary head honcho, Bob...

Equillium Unveils Positive Findings from Phase 2 Clinical Study of Itolizumab Equillium, Inc. (Nasdaq: EQ), a leading clinical-stage biotechnology company that harnesses a deep understanding of immunobiology, has recently shared promising topline results from its Phase 2 study on itolizumab. This study focuses on addressing moderate to severe ulcerative colitis (UC)...

Super Micro Computer's AI Demand Outlook Super Micro Computer (NASDAQ: SMCI) is at a crossroads as it prepares to unveil its fiscal fourth-quarter earnings. The company operates within a complex marketplace characterized by rising demand in the AI server domain, which is promising for long-term growth. However, there are immediate concerns relating to market visibility...

Transforming Your Investment with Toll Brothers Over the past decade, Toll Brothers (NYSE: TOL) has delivered exceptional performance, significantly outperforming the overall market by an impressive 6.05% annually. This remarkable achievement translates to an average annual return of 17.24%. As investors explore opportunities in the market, it's crucial to recognize the...

Transforming Business Analytics with Milky Way Tredence, a pioneering company in data science and AI solutions, has recently launched an innovative platform called Milky Way. This platform represents a significant leap forward in decision intelligence, offering a multi-agent decision system that revolutionizes how businesses harness data. By deploying numerous specialized...

Former CEO of Abercrombie & Fitch on Trial Mike Jeffries, the former chief executive of Abercrombie & Fitch, is at the center of a serious legal battle as he prepares to enter his plea related to actionable allegations of running an extensive international sex trafficking and prostitution network. This fascinating case reveals the complexities and darker undertones behind...